Acrivon Therapeutics Inc....

NASDAQ: ACRV · Real-Time Price · USD
1.36
0.04 (3.03%)
At close: Aug 22, 2025, 3:59 PM
1.38
1.46%
After-hours: Aug 22, 2025, 07:44 PM EDT

Acrivon Therapeutics Common Stock Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-80.56M -60.39M -31.17M -16.24M
Depreciation & Amortization
1.01M 536K 364K 37K
Stock-Based Compensation
14.29M 11.62M 2.19M 497K
Other Working Capital
6.02M 4.53M -1.29M -470K
Other Non-Cash Items
-2.85M 1.06M 33K 1.14M
Deferred Income Tax
n/a -3.61M n/a 255K
Change in Working Capital
2.44M 8.14M -1.53M 328K
Operating Cash Flow
-65.67M -42.64M -30.12M -13.98M
Capital Expenditures
-2.77M -1.29M -2.17M -238K
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-202.93M -56.53M -150.18M n/a
Sales Maturities Of Investments
153.92M 108.53M 10.67M n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-51.77M 50.72M -141.68M -238K
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
51.03M -1.3M -2.75M 1K
Financial Cash Flow
121.03M -1.55M 101.71M 112.22M
Net Cash Flow
3.59M 6.52M -70.08M 98M
Free Cash Flow
-68.44M -43.93M -32.28M -14.22M